An official website of the United States government
Home
Name
OSI-211
Alternate Names
None
Abbreviations
None
Category
Chemotherapy
Subcategory
Topoisomerase inhibitor
NSC Number
None
Primary Site
Lung
ovarian cancer
Histology
None
Remarks
Phase II SCLC, ovarian Toposiomerase I inhibitor. OSI Pharmaceuticals, Gilead Sciences.
Coding
This drug should be coded
